Recent developments of HDAC inhibitors: Emerging indications and novel moleculesAndrey D. Bondarev, Helgi B. Schiöth|British Journal of Clinical Pharmacology|2021Cited by 407
Olesoxime in neurodegenerative diseases: Scrutinising a promising drug candidateJonasz Jeremiasz Weber, Huu Phuc Nguyen, Laura E. Clemensson et al.|Biochemical Pharmacology|2019Cited by 30
Hydroxymethylglutaryl‐CoA reductase activity is essential for mitochondrial β‐oxidation of fatty acids to prevent lethal accumulation of long‐chain acylcarnitines in the mouse liverEdgars Liepinsh, Helgi B. Schiöth|British Journal of Pharmacology|2024Cited by 13